未登录 分享 收藏
分享 收藏
分享 收藏
Development of a selective androgen receptor modulator for transdermal use in hypogonadal patients Krishnan, V; Patel, N. J.; Mackrell, J. G.; Sweetana, S. A.; Bullock, H.; Ma, Y. L.; Waterhouse, T. H.; Yaden, B. C.; Henck, J.; Zeng, Q. Q.; Gavardinas, K.; Jadhav, P.; Saeed, A.; Garcia-Losada, P.; Robins, D. A.; Benson, C. T. 分享 收藏
Exposure - response (overall survival [OS]) analyses of patients with unresectable pancreatic cancer (PC) treated with galunisertib plus gemcitabine (GG) or gemcitabine plus placebo (GP) in a randomized phase 2, double-blind study Gueorguieva, Ivelina; Tabernero, Josep; Melisi, Davide; Waterhouse, Timothy H.; Miles, Colin; Desaiah, Durisala; Lahn, Michael M.; Cleverly, Ann; Benhadji, Karim A. 分享 收藏
Evaluation of Various Static In Vitro-In Vivo Extrapolation Models for Risk Assessment of the CYP3A Inhibition Potential of an Investigational Drug Vieiral, Md L. T.; Kirby, B.; Ragueneau-Majlessi, I.; Galetin, A.; Chien, J. Y. L.; Einolf, H. J.; Fahmi, O. A.; Fischer, V.; Fretland, A.; Grime, K.; Hall, S. D.; Higgs, R.; Plowchalk, D.; Riley, R.; Seibert, E.; Skordos, K.; Snoeys, J.; Venkatakrishnan, K.; Waterhouse, T.; Obach, R. S.; Berglund, E. G.; Zhang, L.; Zhao, P.; Reynolds, K. S.; Huang, S-M 分享 收藏
分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
